ライフサイエンスコーパス: extremity

1 sleep disturbances, minor wheezing, and cold extremities).

2 thorax, abdomen, lower extremity, and upper extremity.

3 perties of information such as diagnosticity/extremity.

4 l (tibial nerve) nerve segments of the lower extremity.

5 llowed by patchy muscle paresis in the upper extremity.

6 d 6 required amputation of part of the lower extremity.

7 cluding the chest, spine, head and neck, and extremities.

8 ight cases, of which seven were in the lower extremities.

9 nfirmed the distinct dynamics of the two DNA extremities.

10 es the asymmetric electroactivity at its two extremities.

11 ntinuous acquisition when monitored from the extremities.

12 ess in the facial, scapular, trunk and lower extremities.

13 ss of peripheral nerve function in the lower extremities.

14 t the very edge of natural physical-chemical extremities.

15 AESS) and guanidine moieties (HPAESG) at the extremities.

16 mulation did not alter perceived size of own extremities.

17 ntervention for ischemic ulcers of the lower extremities.

18 into a shell-like structure by loading their extremities.

19 s from the dorsolateral pole to ventromedial extremities.

20 of the body, with predominance for the lower extremities.

21 nderstudied topic, particularly in the lower extremities.

22 confluent plaques predominantly on the lower extremities.

23 ons that covered places other than the lower extremities.

24 sively worsening edema of her face and lower extremities.

25 imary central high-grade osteosarcoma of the extremities.

26 ised pruritic erythematous rash on trunk and extremities.

27 ric maculopapular rashes involving trunk and extremities.

28 festations of venous thrombosis at the lower extremities.

29 acterised by necrotic gashes to the head and extremities.

30 liposuction, including 23 upper and 18 lower extremities.

31 ssue expansion, particularly in the proximal extremities.

32 , osteonecrosis of the jaw (17 [3%], pain in extremity (12 [2%]), and anaemia (11 [2%]).

33 the hybrid suite included: laparotomy (57%), extremity (14%), thoracotomy/sternotomy (12%), angioembo

34 11/77, 14.2%), abdomen (16/77, 20.7%), lower extremity (48/77, 62.3%), and upper extremity (5/77, 6.4

35 ), lower extremity (48/77, 62.3%), and upper extremity (5/77, 6.4%).

36 of anatomic injuries to regions such as the extremities, abdomen, and thorax.

37 l circulatory support via percutaneous upper-extremity access.

38 ltiple lesions on sun-exposed areas of their extremities after a median of 13 months (range, 4-18 mon

39 of global spinal balance together with lower extremity alignment should be strongly recommended.

40 ately 2-fold higher risk of below-knee lower extremity amputation (0.17 versus 0.09 events per 100 pe

41 rization (4.0%; 95% CI, 2.6%-5.4%) and lower extremity amputation (2.3%; 95% CI, 0.8%-3.8%).

42 rates, although some increase rates of lower-extremity amputation (LEA).

43 02 through 2014 to analyze patterns of lower extremity amputation in the last year of life compared w

44 aries with ESRD underwent at least one lower extremity amputation in their last year of life compared

45 ne in ten patients with ESRD undergoes lower extremity amputation in their last year of life.

46 Lower extremity amputation is common among patients with ESRD,

47 Persons with lower extremity amputation often exhibit abnormal trunk motion

48 remains unclear whether the below-knee lower extremity amputation risk extends across the class of me

49 RD showed that those who had undergone lower extremity amputation were substantially more likely than

50 ripheral arterial revascularization or lower extremity amputation, 4.6% died, and the median cost of

51 s after coronary revascularization and lower extremity amputation, and the majority of bleeding event

52 heral, coronary revascularization, and lower extremity amputation.

53 r events and higher risk of below-knee lower extremity amputation.

54 ratory safety end point was below-knee lower extremity amputation.

55 larization or endovascular surgery and lower extremity amputation.

56 Over 60% of lower extremity amputations are performed in patients with dia

57 About 85% of lower extremity amputations in diabetes are attributed to deep

58 Lower extremity amputations were similarly increased in the se

59 y chronic vessel immaturity leading to lower extremity amputations.

60 nd who underwent CT angiography of the lower extremities and 32 patients who tested negative for SARS

61 muscle hernias are not uncommon in the lower extremities and are a rare cause of chronic leg pain.

62 P with an acellular perfusate in human upper extremities and compare with the current gold standard o

63 P = .05), and chronic fractures affected the extremities and nasal bone (P < .01 and P = .05, respect

64 with venous malformations (VM) of the lower extremities and to demonstrate multidisciplinary therape

65 40 to lower than 50 Gy appears adequate for extremities and/or trunk stage I to III MCC, with OS equ

66 ears or older with stage I to III MCC of the extremities and/or trunk treated with definitive surgery

67 ation in long-term memory, enhanced attitude extremity and accessibility, enhanced attitude impact on

68 ace area contracted in the motor (i.e. lower extremity) and pulvinar thalamus, and striatum; and expa

69 istry, including 8,155 carotid, 21,428 lower extremity, and 5,800 aortic aneurysm repair procedures.

70 c clinical outcomes following carotid, lower extremity, and aortic aneurysm repair procedures.

71 uch as head and neck, thorax, abdomen, lower extremity, and upper extremity.

72 le brachial index >/=1.4 who underwent lower extremity angiograms within 1 year were included.

73 taking carotid [aOR:1.04 (0.84-1.28)], lower extremity [aOR:1.03 (0.84-1.26)], and aortic [aOR:0.96 (

74 ith peripheral arterial disease of the lower extremities are at higher risk of major vascular complic

75 DEXA measurements showed lower extremities are more affected than upper extremities (av

76 Inflammatory dermatoses of the lower extremity are often misdiagnosed as cellulitis (aka "pse

77 ltivessel coronary artery disease, and lower extremity arterial disease.

78 1 was found to be elevated in diseased lower-extremity arterial intima of individuals with peripheral

79 avirus disease 2019 is associated with lower-extremity arterial thrombosis characterized by a greater

80 of this study was to determine whether lower-extremity arterial thrombosis was associated with COVID-

81 imb revascularization in patients with lower-extremity arterial trauma is central to decisions betwee

82 th new or restenotic lesions in native upper-extremity arteriovenous fistulas were eligible for parti

83 lestatic jaundice, oedema or erythema of the extremity associated with desquamation of feet and hands

84 Participants underwent MRI of the lower extremities at baseline and 10-month follow-up (January

85 wer extremities are more affected than upper extremities (average fat z scores of 2.1 and 0.6, respec

86 In contrast, body and extremity bone sarcoma incidence flattened after adolesc

87 tissue, 51.6%), one quarter in the body and extremities (bone, 29.5%; soft tissue, 25.0%), and appro

88 litary training (IMT), particularly in lower-extremity bones such as the tibia.

89 the lesions (87.5%) were localised in lower extremity bones.

90 3 (FGF23), hypophosphataemia, rickets, lower extremity bowing, and growth impairment.

91 d amputation, and 1 patient required a lower-extremity bypass procedure because of gangrenous toes.

92 rge urban hospital with a diagnosis of lower extremity cellulitis between June 2010 and December 2012

93 Misdiagnosis of lower extremity cellulitis is common and may lead to unnecessa

94 in patients admitted for treatment of lower extremity cellulitis.

95 mitted from the ED with a diagnosis of lower extremity cellulitis.

96 AA risk variants with aneurysms in the lower extremity, cerebral, and iliac arterial beds, and derive

97 da with unresected, newly diagnosed trunk or extremity chemotherapy-sensitive soft tissue sarcoma, wh

98 pressed and confirmed entry into all 4 lower extremity compartments.

99 Thus, distal upper extremity control influenced by LPMC, including grasping

100 authors noted an increase in positive lower-extremity CT angiography examinations in patients who pr

101 All patients were evaluated by lower extremities CTA protocol allowing similar image quality

102 Incidence rates for lower extremity deep vein thrombosis (DVT) range from 88 to 11

103 est appears reliable for screening for lower extremity deep venous thrombosis at or above a concentra

104 examinations, with 12 cases (16.7%) of lower extremity deep venous thrombosis identified.

105 Lower extremity deep venous thrombosis is prevalent in coronav

106 uartile range, 3,176-30,770 ng/mL] for lower extremity deep venous thrombosis vs 2,087 ng/mL [interqu

107 e spectrum of ipsilateral thoracic and upper extremity deformities.

108 cause SMALED2 (spinal muscular atrophy lower extremity dominant 2), and a subset have recently been r

109 Patients underwent a screening lower-extremity duplex ultrasound approximately 1 month after

110 Patients with signs or symptoms of lower extremity DVT, such as swelling (71%) or a cramping or p

111 Upper-extremity dysfunction was not associated with SPA incomp

112 Lower-extremity edema (LEE) is an underreported complication o

113 failure to thrive, liver dysfunction, lower extremity edema and dysmorphic features.

114 Conclusion Lower-extremity edema developed in more than 50% of study pati

115 Lower-extremity edema portends worse survival.

116 ness of breath at rest, orthopnea, and lower extremity edema.

117 uciate-retaining (CR)-TKR in a virtual lower extremity emulated by a musculoskeletal multibody model.

118 bridges identified those patients with lower extremity evoked potentials and better clinical recovery

119 ed CCC as a diffuse rash involving the body, extremities, face or scalp, and/or funisitis, presenting

120 uring extremity vascular exposures and lower extremity fasciotomy in fresh cadavers before and after

121 quently recommended radiography of the lower extremities ( Fig 3 ).

122 recovery rule for the Fugl-Meyer motor upper extremity (FM-UE) scale.

123 city in humans, we casted the dominant upper extremity for 2 weeks and tracked changes in functional

124 spinal cord paralysis, venous injury, lower extremity fracture, pelvic fracture, central line, intra

125 fracture healing or weight bearing for lower extremity fractures.

126 Forty lower extremities from 20 adult cadavers, embalmed with Thiel'

127 Functional (including the lower extremity Fugl-Meyer assessment [LE-FM; primary outcome

128 multaneous execution of a sensor-based upper-extremity function (UEF) motor task (normal or rapid spe

129 B) test is an objective measurement of lower extremity function (walk speed, balance, chair stands).

130 Mice administered gabapentin recovered upper extremity function after cervical SCI.

131 e SPA is not associated with a loss of upper-extremity function after transradial catheterization.

132 obust KT candidates and improvement in lower extremity function are potential ways to improve surviva

133 Upper-extremity function was assessed at baseline and 2-year f

134 Upper extremity function was evaluated with the validated Quic

135 imal therapy for a stroke patient with upper extremity hemiparesis, we propose a cortico-basal gangli

136 that other painful conditions of the distal extremities (ie, neuropathy related to human immunodefic

137 Using a rat model of upper extremity impairments after ischemic stroke, we examined

138 d cortical lesions had the most severe upper extremity impairments, particularly somatosensory functi

139 Here, we performed MRIs of the lower extremities in 36 individuals with FSHD, followed by nee

140 life, mostly affecting arteries in the lower extremities in elderly individuals.

141 keletal muscles weakness and numbness of the extremities in exposed human and laboratory animals.

142 MRI of the lower extremities included the Dixon sequence, multicomponent

143 ons), retinal manifestations, and defects on extremities including congenital contractures and hypert

144 in patients with early-onset pain in distal extremities including joints and gastrointestinal distur

145 y skin lesions involving the head, trunk and extremities, including palms of hands and soles of feet.

146 otopic ossification (HO) after blast-related extremity injury and traumatic injuries, respectively.

147 brosis in ischemia reperfusion and traumatic extremity injury.

148 On each of its extremities, it contained a mixed of vagal afferents and

149 es; the use of a compression wrap for closed extremity joint injuries; and temporary storage of an av

150 Previous research has investigated lower extremity joint mechanics between young and elderly peop

151 racterize associations between altered lower extremity joint moments and altered trunk dynamics in pe

152 (BPCI) program, bundled paymtents for lower-extremity joint replacement (LEJR) are associated with 2

153 ypass graft (CABG), lung resection, or lower extremity joint replacement (LEJR) were identified in th

154 Among Medicare patients undergoing lower extremity joint replacement from 2013-2017, the BPCI mod

155 ffective treatment for patients with chronic extremity lymphedema.

156 traspasticity with predominance in the lower extremities, mild cerebellar atrophy, and hyperekplexia-

157 In this study, upper extremity moles, a higher ability to achieve a tan, and

158 photothrombotic approach for modeling upper-extremity motor impairments extends to the artery-target

159 (i.e. motor caudate) predicted better lower extremity motor score at 2-years.

160 e and change in upper-extremity motor, lower-extremity motor, light touch, and pin prick scores after

161 irment Scale (AIS) grade and change in upper-extremity motor, lower-extremity motor, light touch, and

162 ial expressions, functional status entailing extremity movement and postures, and environmental facto

163 erlapping representations of upper and lower extremity movement kinematics in subthalamic units and o

164 mputational model of three-dimensional upper extremity movements that reproduces well-known features

165 units and expressions, head pose variation, extremity movements, sound pressure levels, light intens

166 nd (1)H MR spectroscopy; and correlate upper extremity MRI and (1)H MR spectroscopy measures to funct

167 A full lower extremity MRI and a detailed knee MRI were taken.

168 monstrate the feasibility of acquiring upper extremity MRI and proton ((1)H) MR spectroscopy measures

169 Background Upper extremity MRI and proton MR spectroscopy are increasingl

170 targeting physical activity increased lower extremity muscle cross-sectional area in patients with m

171 e training improved exercise capacity, lower extremity muscle strength, and health-related quality of

172 ndividuals with DMD; compare upper and lower extremity muscles by using MRI and (1)H MR spectroscopy;

173 In standing, coordinated activation of lower extremity muscles can be simplified by common neural inp

174 d early and progressive involvement of upper extremity muscles in Duchenne muscular dystrophy (DMD) a

175 ulating behavioral intervention on the lower extremity muscles of patients with DM1 with longitudinal

176 Three of the four extremities of each double helix are attached to two mic

177 realistically manipulate the length of whole extremities of first person biometric avatars under vest

178 ctivity of somatosensory gating in the lower extremities of healthy human participants.

179 hat assembly of this adhesion complex at the extremities of migrating oligodendroglial processes prom

180 onal state of lymphatic vessels in the lower extremities of patients with a Fontan circulation (n=10)

181 s of connective tissue nevi on the trunk and extremities of patients with tuberous sclerosis complex.

182 Numerous termini correlated with the extremities of small RNA footprints or predicted stem-lo

183 , which preferentially develops in the lower extremities of the body where blood vessels are often po

184 -N transition with the I and N phases at the extremities of the channel, starting from an initially s

185 application of an electric potential to the extremities of the device.

186 We reveal that the N-terminal extremity of Galphas contains a ubiquitin-interacting mo

187 th substantial disparities in the timing and extremity of impacts even without distancing interventio

188 ntative sample of US adults, we find that as extremity of opposition to and concern about genetically

189 t the positively and negatively valent polar-extremity of stimulus sets reported in the literature.

190 Moreover, the N-terminal extremity of the channel, called N-Cap, has been suggest

191 ndary, slow expansion phase during which the extremity of the circular plate seeks contact with the m

192 apical surface proteins (RASP) that cap the extremity of the rhoptry.

193 nge of stimulus sets, differing by the polar-extremity of their positively and negatively valent subs

194 lar revascularization procedure in the lower extremities or abdomen in Denmark, from 2000 to 2016.

195 97 patients who had osteoid osteoma in lower extremities or pelvic bones, 73% had muscular atrophy.

196 following resection of localized MCC of the extremities or trunk.

197 o September 2017 for primary, nonmetastatic, extremity or truncal LPS of known subtype.

198 high-risk STS (grade 3; size, >= 5 cm) of an extremity or trunk wall, belonging to one of the followi

199 locally advanced soft-tissue sarcoma of the extremity or trunk wall, of any histological grade, and

200 e symptoms such as diarrhoea, lesions on the extremities, or even death.

201 l effusion, muscular atrophy in the affected extremity, osteopaenia, and posture deterioration were n

202 In this largest study to date with extremity osteosarcomas, we observed the occurrence of P

203 near the radiotherapy field) versus body and extremities (out of field).

204 mages (MRI) of patients with VM of the lower extremities, over a six-year period, were reviewed retro

205 a clinically relevant rodent model of upper extremity overuse injury.

206 rer vibration perception in the distal lower extremities (P = .008, adjusting for age, height, and te

207 MPNSTs occurred most often in the extremities (p = 0.006).

208 the adjusted hazard ratio of ischemic lower-extremity PAD (1.54 [95% CI, 1.14-2.10]) (p = 0.005).

209 During the follow-up period, ischemic lower-extremity PAD developed in 24.4% of hemodialysis patient

210 scularization strategy for symptomatic lower extremity PAD is not established.

211 hemodialysis patients in whom ischemic lower-extremity PAD occurred (3.03% [IQR, 2.36-4.54], n = 22)

212 ients until the occurrence of ischemic lower-extremity PAD.

213 nt discontinued treatment because of grade 2 extremity pain and no treatment-related deaths were obse

214 21 to 64 years with moderate to severe acute extremity pain enrolled from July 2015 to August 2016.

215 For patients presenting to the ED with acute extremity pain, there were no statistically significant

216 y history of wobbly gait and bilateral lower extremity paresthesia without confusion.

217 y history of wobbly gait and bilateral lower extremity paresthesia without confusion.

218 omy, EVAR, open AAA repair, bypass for lower extremity peripheral arterial disease - in Ontario, Cana

219 nal aortic diameter is associated with lower-extremity peripheral artery disease (LE-PAD).

220 Lower extremity peripheral artery disease (PAD) burden differs

221 Patients with lower-extremity peripheral artery disease (PAD) have greater f

222 s, total number of recommendations for lower extremity peripheral artery disease in the current guide

223 ic kidney disease is a risk factor for lower-extremity peripheral artery disease.

224 12 mo of vitamin D supplementation on lower-extremity power and function in older community-dwelling

225 (on average) over 12 mo did not affect lower-extremity power, strength, or lean mass in older communi

226 (MCD) or spinal muscular atrophy with lower extremity predominance (SMALED), as well as three mutati

227 ry of peripheral artery disease of the lower extremities (previous peripheral bypass surgery or angio

228 imerization interface and an important C-ter extremity providing the first in-depth functional archit

229 ts per year attributed to misdiagnosed lower extremity pseudocellulitis.

230 ective analysis of patients undergoing lower extremity PVI in the Vascular Quality Initiative (2017-2

231 icoagulation or on DAPT at the time of lower extremity PVI, prescription of DAPT following interventi

232 iated with DAPT prescription following lower extremity PVI.

233 in differential diagnosis of bilateral lower extremity rash in patients with CD after infectious, mal

234 tekinumab, she developed new bilateral lower extremity rash initially treated with levofloxacin for p

235 ecovery is an important determinant of upper extremity recovery after stroke and has been described b

236 al sites such as cerebral, splanchnic, upper-extremity, renal, ovarian, or retinal veins.

237 ions of 111% and 115% in the upper and lower extremities, respectively, at one year post-operatively.

238 d endarterectomy (8%-IVSR vs. 7%-VSF), lower extremity revascularization (19%-IVSR vs. 16%-VSF), and

239 9-1.31]; P<0.001) but not MALE or MALE/lower extremity revascularization (HR, 1.02 [95% CI, 0.84-1.23

240 =0.062), and an increased risk of MALE/lower extremity revascularization (HR, 1.08 [95% CI, 1.04-1.11

241 eral artery disease who have undergone lower-extremity revascularization are at high risk for major a

242 atients enrolled based on the previous lower extremity revascularization criterion.

243 ntervention after endovascular or open lower extremity revascularization for propensity-score matched

244 tients with symptomatic PAD undergoing lower extremity revascularization randomized to rivaroxaban 2.

245 dition of rivaroxaban to aspirin after lower extremity revascularization regardless of concomitant cl

246 omparable between sexes, whereas prior lower extremity revascularization was reported less frequently

247 heral artery disease who had undergone lower-extremity revascularization, rivaroxaban at a dose of 2.

248 nkle-brachial index <=0.80 or previous lower extremity revascularization.

249 for any MACE, MALE, and MALE including lower extremity revascularization.

250 cardiac and ischemic limb events after lower extremity revascularization.

251 g sarcoma trials was assessed by the Toronto Extremity Salvage Score, Short-Form Health Survey (SF-36

252 Unlike for extremity sarcomas, the efficacy of radiotherapy for ret

253 ent, systolic blood pressure, upper-to-lower-extremity SBP gradient, aortic isthmus ratio, presence o

254 e was change in Fugl-Meyer Assessment, upper-extremity score (FMA-UE) from baseline to the first day

255 ignificantly better performance than mangled extremity severity score at predicting the need for ampu

256 BN performance was compared to the mangled extremity severity score.

257 tentially curative for primary nonmetastatic extremity soft tissue sarcomas.

258 s for microsurgical reconstructions of lower extremity soft-tissue defects.

259 .5%; 95% CI, 2.3% to 4.8%), whereas body and extremity soft-tissue sarcoma incidence was rare until a

260 tudies in all patients associated with lower-extremity spasticity (6), cardiac abnormalities or cardi

261 e management of acute pain after minor upper extremity surgeries increases overall opioid use when co

262 pain such as brachial plexopathy from upper extremity suspension or lumbosacral plexus injury from l

263 d and accuracy within a more practical upper-extremity test (instead of walking) may provide enough c

264 ory function beginning distally in the lower extremities that is also characterized by pain and subst

265 s developed necrotizing fasciitis of a lower extremity that required amputation, and 1 patient requir

266 bed tracheal occlusion (TO) at the posterior extremities the DTTs.

267 Using the contra lateral side of the extremities to create a template for an ipsilateral reco

268 They ferry antigen from the extremities to T cells and are essential for the initiat

269 d cerebellar regions controlling the disused extremity to functionally disconnect from the rest of th

270 maging field to include the vertex and lower extremities (total-body acquisition) affects bone metast

271 Here, we present a case report of an upper extremity transplant recipient with trauma-induced rejec

272 d antibody-mediated rejection (AMR) in upper extremity transplantation (UET) remains to be establishe

273 Volumetric muscle loss (VML) resulting from extremity trauma presents chronic and persistent functio

274 imary central high-grade osteosarcoma of the extremities, treated between 1980 and 2010.

275 ostic significance of histologic subtype for extremity/truncal liposarcoma (LPS).

276 strongly associated with DSD, DR, and LR in extremity/truncal LPS.

277 population for head and neck versus body and extremity tumors for both bone (SIR, 2,213; 95% CI, 1,67

278 h secondary lymphedema of the upper or lower extremity (UEL/LEL).

279 tatewide death data, all patients with lower extremity ulcers and a diagnosis of peripheral artery di

280 tal, 37 patients with a confirmed STS of the extremities underwent (18)F-FDG PET/MRI before and after

281 Extremity vascular and fasciotomy performance evaluation

282 ing, colectomy, ventral hernia repair, lower extremity vascular bypass, lung resection, pancreatic re

283 Performance was measured during extremity vascular exposures and lower extremity fasciot

284 Lower extremities vessel enhancement and image noise were quan

285 es quality of life, and additionally reduces extremity volumes, infection rates and reliance on outpa

286 of EIM phase ratio trajectories in the upper extremity was observed by 6 months of -0.074/month, p =

287 nt had a pacemaker; instead, CT of the lower extremity was performed ( Fig 3a , 3b ).

288 nt had a pacemaker; instead, CT of the lower extremity was performed.

289 the illness and can occur without preceding extremity weakness.

290 ed respiratory involvement without report of extremity weakness.

291 rs that cause progressive debilitating focal extremity weakness.

292 Six upper extremities were assigned to either MP (n = 3) or SCS (n

293 MP-extremities were perfused with oxygenated Steen solution

294 Lower extremities were the significantly more affected body re

295 fication pattern in mammals with specialized extremities (whales, bats, jerboa) revealed that SOC dev

296 d increased muscle fat fraction in the lower extremities, which correlates with disease duration (thi

297 d by inadequate venous return from the lower extremities, which may arise from intravenous obstructio

298 nts with cutaneous melanoma of the trunk and extremities who were randomly assigned (1:1) to undergo

299 cattered non-palpable petechiae on the lower extremities with subsequent involvement of abdomen, lowe

300 and high complication rates associated with extremity wounds in recent military conflicts have highl